The aim of the study was the assessment of the intensity of M2 macrophage infiltration defined as CD68+/iNOS− and the intensity of CD8+/FoxP3+ lymphocyte infiltration as prognostic factors for disease-free survival (DFS) and overall survival (OS) in patients who underwent surgical treatment due to CRC. This evidence concerns the gene CD8A and colorectal carcinoma.